The last two decades have witnessed a significant increase in scientific literature describing the healthiness of dietary supplements, fortified foods, and nutraceuticals. So far, the majority of these products have demonstrated their biological effects and mechanisms of action through in vitro testing and efficacy assessment in laboratory animals. For those products showing greater potential, it is now time to seek confirmation through clinical trials.
This scientific objective carries significant ethical implications. Nowadays, dietary supplements and nutraceuticals are sold as over-the-counter products. Consumers, often influenced by advertisements, purchase them without medical prescriptions and without awareness of whether they are supported by clinical evidence. On the contrary, the health claims of dietary supplements must be supported by robust scientific evidence to protect consumers and promote confidence in dietary supplements.
This Research Topic welcomes original research, reviews, and other article types discussing clinical evidence for the effects of dietary supplements and nutraceuticals on human health.
Potential subtopics for exploration include, but are not limited to, the effect of dietary supplements and nutraceuticals in cardiovascular disease, metabolic syndrome, muscle-related pathology, geriatrics, dermatology, and trichology. Manuscripts where dietary supplements and nutraceuticals are tested as support to traditional pharmaceutical therapies are particularly welcome.
Manuscripts presenting in vitro or laboratory animal studies are out of the scope of this Research Topic. Manuscripts approaching in laboratory animals ADME aspects of complex nutraceutical formulations constitute an exception and might be considered depending on their scientific relevance.
Topic Editor Ettore Novellino is a scientific advisor for NGN Healthcare. All other Topic Editors declare no conflicts of interest.
Keywords:
dietary supplements, clinical trials, nutraceuticals, CVD, metabolic syndrome
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
The last two decades have witnessed a significant increase in scientific literature describing the healthiness of dietary supplements, fortified foods, and nutraceuticals. So far, the majority of these products have demonstrated their biological effects and mechanisms of action through in vitro testing and efficacy assessment in laboratory animals. For those products showing greater potential, it is now time to seek confirmation through clinical trials.
This scientific objective carries significant ethical implications. Nowadays, dietary supplements and nutraceuticals are sold as over-the-counter products. Consumers, often influenced by advertisements, purchase them without medical prescriptions and without awareness of whether they are supported by clinical evidence. On the contrary, the health claims of dietary supplements must be supported by robust scientific evidence to protect consumers and promote confidence in dietary supplements.
This Research Topic welcomes original research, reviews, and other article types discussing clinical evidence for the effects of dietary supplements and nutraceuticals on human health.
Potential subtopics for exploration include, but are not limited to, the effect of dietary supplements and nutraceuticals in cardiovascular disease, metabolic syndrome, muscle-related pathology, geriatrics, dermatology, and trichology. Manuscripts where dietary supplements and nutraceuticals are tested as support to traditional pharmaceutical therapies are particularly welcome.
Manuscripts presenting in vitro or laboratory animal studies are out of the scope of this Research Topic. Manuscripts approaching in laboratory animals ADME aspects of complex nutraceutical formulations constitute an exception and might be considered depending on their scientific relevance.
Topic Editor Ettore Novellino is a scientific advisor for NGN Healthcare. All other Topic Editors declare no conflicts of interest.
Keywords:
dietary supplements, clinical trials, nutraceuticals, CVD, metabolic syndrome
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.